| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.22 | 0.001 |